239 related articles for article (PubMed ID: 25302552)
1. Phototherapy for the treatment of cutaneous graft versus host disease.
Garbutcheon-Singh KB; Fernández-Peñas P
Australas J Dermatol; 2015 May; 56(2):93-9. PubMed ID: 25302552
[TBL] [Abstract][Full Text] [Related]
2. Narrowband UV-B Phototherapy for Steroid-Refractory Sclerotic Chronic Cutaneous Graft-vs-Host Disease.
Sorenson E; McAndrew R; Patel V; Logan AC; Koo J; Levin E
JAMA Dermatol; 2015 Jun; 151(6):635-7. PubMed ID: 25806783
[TBL] [Abstract][Full Text] [Related]
3. Phototherapy in the treatment of cutaneous graft-versus-host disease. Our preliminary experience in resistant patients.
Aubin F; Brion A; Deconinck E; Plouvier E; Hervé P; Humbert P; Cahn JY
Transplantation; 1995 Jan; 59(1):151-5. PubMed ID: 7839420
[TBL] [Abstract][Full Text] [Related]
4. UV treatment of chronic skin graft-versus-host disease--focus on UVA1 and extracorporeal photopheresis.
Greinix HT; Tanew A
Curr Probl Dermatol; 2012; 43():116-31. PubMed ID: 22377925
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous manifestations of graft-versus-host disease: role of the dermatologist.
Kavand S; Lehman JS; Hashmi S; Gibson LE; El-Azhary RA
Int J Dermatol; 2017 Feb; 56(2):131-140. PubMed ID: 27658806
[TBL] [Abstract][Full Text] [Related]
6. Medium dose long-wavelength ultraviolet A (UVA1) phototherapy for the treatment of acute and chronic graft-versus-host disease of the skin.
Wetzig T; Sticherling M; Simon JC; Hegenbart U; Niederwieser D; Al-Ali HK
Bone Marrow Transplant; 2005 Mar; 35(5):515-9. PubMed ID: 15665847
[TBL] [Abstract][Full Text] [Related]
7. Pediatric Cutaneous Graft Versus Host Disease: A Review.
Shi CR; Huang JT; Nambudiri VE
Curr Pediatr Rev; 2017; 13(2):100-110. PubMed ID: 28641548
[TBL] [Abstract][Full Text] [Related]
8. The role of phototherapy in cutaneous chronic graft-vs-host disease: a retrospective study and review of the literature.
Ballester-Sánchez R; Navarro-Mira MÁ; de Unamuno-Bustos B; Pujol-Marco C; Sanz-Caballer J; Botella-Estrada R
Actas Dermosifiliogr; 2015 Oct; 106(8):651-7. PubMed ID: 26032871
[TBL] [Abstract][Full Text] [Related]
9. Annular plaques: An unusual manifestation of graft-versus-host disease.
Alexander LJ; Paravar T; Duvic M; Prieto V; Hymes SR
Dermatol Online J; 2012 Jun; 18(6):4. PubMed ID: 22747928
[TBL] [Abstract][Full Text] [Related]
10. German-Austrian-Swiss Consensus Conference on clinical practice in chronic graft-versus-host disease (GVHD): guidance for supportive therapy of chronic cutaneous and musculoskeletal GVHD.
Marks C; Stadler M; Häusermann P; Wolff D; Buchholz S; Stary G; Lee S; Lawitschka A; Bertz H
Br J Dermatol; 2011 Jul; 165(1):18-29. PubMed ID: 21466534
[TBL] [Abstract][Full Text] [Related]
11. Psoralen plus ultraviolet-A-bath photochemotherapy as an adjunct treatment modality in cutaneous chronic graft versus host disease.
Leiter U; Kaskel P; Krähn G; Gottlöber P; Bunjes D; Peter RU; Kerscher M
Photodermatol Photoimmunol Photomed; 2002 Aug; 18(4):183-90. PubMed ID: 12390673
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous graft-versus-host disease after hematopoietic stem cell transplant - a review.
Villarreal CD; Alanis JC; Pérez JC; Candiani JO
An Bras Dermatol; 2016; 91(3):336-43. PubMed ID: 27438202
[TBL] [Abstract][Full Text] [Related]
13. Treatment of acute graft-versus-host disease with PUVA (psoralen and ultraviolet irradiation): results of a pilot study.
Wiesmann A; Weller A; Lischka G; Klingebiel T; Kanz L; Einsele H
Bone Marrow Transplant; 1999 Jan; 23(2):151-5. PubMed ID: 10197800
[TBL] [Abstract][Full Text] [Related]
14. Established and Emerging Treatments of Skin GvHD.
Link-Rachner CS; Sockel K; Schuetz C
Front Immunol; 2022; 13():838494. PubMed ID: 35185931
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous Graft-Versus-Host Disease: Diagnosis and Treatment.
Strong Rodrigues K; Oliveira-Ribeiro C; de Abreu Fiuza Gomes S; Knobler R
Am J Clin Dermatol; 2018 Feb; 19(1):33-50. PubMed ID: 28656563
[TBL] [Abstract][Full Text] [Related]
16. Eczematoid graft-vs-host disease: a novel form of chronic cutaneous graft-vs-host disease and its response to psoralen UV-A therapy.
Creamer D; Martyn-Simmons CL; Osborne G; Kenyon M; Salisbury JR; Devereux S; Pagliuca A; Ho AY; Mufti GJ; du Vivier AW
Arch Dermatol; 2007 Sep; 143(9):1157-62. PubMed ID: 17875877
[TBL] [Abstract][Full Text] [Related]
17. UVA (UVA-1) therapy for the treatment of acute GVHD of the skin.
Schlaak M; Schwind S; Wetzig T; Maschke J; Treudler R; Basara N; Lange T; Simon JC; Niederwieser D; Al-Ali HK
Bone Marrow Transplant; 2010 Dec; 45(12):1741-8. PubMed ID: 20921941
[TBL] [Abstract][Full Text] [Related]
18. Treatment rationale and design of a phase II study of narrow-band ultraviolet B phototherapy for cutaneous steroid-refractory acute graft-vs-host disease following allogenic stem-cell transplantation.
Asai J; Yamaguchi J; Tsukamoto T; Chinen Y; Shimura Y; Kobayashi T; Katoh N; Kuroda J
Medicine (Baltimore); 2019 Jul; 98(28):e16372. PubMed ID: 31305435
[TBL] [Abstract][Full Text] [Related]
19. The changing face of graft-versus-host disease.
Schaffer JV
Semin Cutan Med Surg; 2006 Dec; 25(4):190-200. PubMed ID: 17174839
[TBL] [Abstract][Full Text] [Related]
20. Nodular Sclerodermatous Chronic Cutaneous Graft-Versus-Host Disease (GvHD): A New Clinicopathological Variant of Cutaneous Sclerodermatous GvHD Resembling Nodular/Keloidal Scleroderma.
Prieto-Torres L; Boggio F; Gruber-Wackernagel A; Cerroni L
Am J Dermatopathol; 2017 Dec; 39(12):910-913. PubMed ID: 28475513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
